Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
about
Pharmacodynamics of citicoline relevant to the treatment of glaucoma.Evaluation of memantine for the treatment of Alzheimer's disease.Alpha2-macroglobulin is a mediator of retinal ganglion cell death in glaucoma.NO donors inhibit Na,K-ATPase activity by a protein kinase G-dependent mechanism in the nonpigmented ciliary epithelium of the porcine eye.
P2860
Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
@ast
Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
@en
Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
@nl
type
label
Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
@ast
Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
@en
Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
@nl
prefLabel
Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
@ast
Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
@en
Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
@nl
P1476
Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
@en
P2093
Hartwick AT
P356
10.1097/00006324-200102000-00008
P577
2001-02-01T00:00:00Z